Publications
- B-Cell Receptor Signaling and Beyond: The Role of Igα (CD79a)/Igβ (CD79b) in Normal and Malignant B Cells2024 | First Faculty of Medicine
- Circulating tumor DNA in Hodgkin lymphoma2022 | First Faculty of Medicine, Third Faculty of Medicine
- Anti-apoptotic MCL1 Protein Represents Critical Survival Molecule for Most Burkitt Lymphomas and BCL2-negative Diffuse Large B-cell Lymphomas2022 | First Faculty of Medicine
- CD31/PECAM-1 impacts engraftment, growth and spread of mantle cell lymphoma cells and positively correlates with extramedullary involvement2021 | First Faculty of Medicine
- Inhibition of PIM Kinases in DLBCL Targets MYC Transcriptional Program and Augments the Efficacy of Anti-CD20 Antibodies2021 | First Faculty of Medicine
- Targeting phosphatidylinositol 3 kinase-beta and -delta for Bruton tyrosine kinase resistance in diffuse large B-cell lymphoma2020 | First Faculty of Medicine
- Cotargeting of BCL2 with venetoclax and MCL1 with S63845 is synthetically lethal in vivo in relapsed mantle cell lymphoma2019 | First Faculty of Medicine, Second Faculty of Medicine
- Association of Germline CHEK2 Gene Variants with Risk and Prognosis of Non-Hodgkin Lymphoma2015 | First Faculty of Medicine
- No association between the TP53 codon 72 polymorphism and risk or prognosis of Hodgkin and non-Hodgkin lymphoma2011 | First Faculty of Medicine, Central Library of Charles University, Second Faculty of Medicine, Third Faculty of Medicine
- Alterations of CHEK2 forkhead-associated domain increase the risk of Hodgkin lymphoma2011 | First Faculty of Medicine, Second Faculty of Medicine, Third Faculty of Medicine
Loading network view...